# Korsana funding rounds and investors

As of 14 Oct 2026, Korsana has raised $150M across 1 verified round on record; latest: $150 million Series A led by TCGX and Wellington Management, announced 18 Feb 2026.

Korsana develops advanced therapeutics aimed at treating neurodegenerative diseases, particularly focusing on Alzheimer's disease.

Website: https://korsana.com  
Page: https://fireround.dev/companies/korsana.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-02-18 | Series A | $150 million | TCGX, Wellington Management | Foresite Capital, Janus Henderson Investors, J.P. Morgan Life Sciences Private Capital, Sanofi Ventures | [korsana.com](https://korsana.com/news/korsana-biosciences-emerges-from-stealth-with-175-millon-in-funding), [biopharmadive.com](https://www.biopharmadive.com/news/korsana-alzheimers-amyloid-beta-plaque-launch/812443) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.